Drug Warnings: Paxil Side Effects and Risks
Get Legal Help Today
Secured with SHA-256 Encryption
UPDATED: Jun 19, 2018
It’s all about you. We want to help you make the right legal decisions.
We strive to help you make confident insurance and legal decisions. Finding trusted and reliable insurance quotes and legal advice should be easy. This doesn’t influence our content. Our opinions are our own.
Editorial Guidelines: We are a free online resource for anyone interested in learning more about legal topics and insurance. Our goal is to be an objective, third-party resource for everything legal and insurance related. We update our site regularly, and all content is reviewed by experts.
Paxil (generic paroxetine hydrochloride) is an antidepressant manufactured by the pharmaceutical giant GlaxoSmithKline. Paxil is approved by the FDA (Food and Drug Administration) to treat depression, anxiety, panic, obsessive-compulsive activity, and post traumatic stress in adults. It’s not approved for the treatment of children under 18, because studies have failed to prove Paxil is an effective treatment for children. Paxil is known as a SSRI (selective serotonin reuptake inhibitor) drug.
Paxil has been the focus of debates about safety and the target of several official warnings.
The FDA issued a December 2005 warning about the risks of birth defects in infants born to women who took Paxil during the first trimester of pregnancy. Paxil increased “the risk of congenital malformations, particularly cardiovascular malformations.” Paxil has been more likely to cause birth defects than other SSRIs.
In March 2006, Health Canada issued a strongly worded warning to all pregnant women to take great care in using SSRIs during pregnancy because of the risk of danger to their babies that could be life threatening. Pregnant women were advised to discuss the dangers with their health care providers.
Studies have linked Paxil in particular to cardiovascular malformations, and one study has linked all SSRIs, including Paxil, with three other malformations, two of the head and one of the abdominal wall.
A 2006 study linked SSRIs with a sometimes fatal lung condition in infants whose mothers had taken the drugs.
In March 2006, an FDA research team reviewed studies on children and suicide and concluded that SSRI use increases risks for suicidal thoughts and behavior in patients under 18. An earlier FDA Public Health Advisory warning was given in October 2003, to inform the public about possible increases in suicide and violence in children and teenagers using Paxil. A few months earlier, in June, the British drug regulatory agency had ruled that Paxil should not be prescribed for children. The FDA has not banned the use of SSRIs for children under 18, in spite of a lack of evidence that the treatment with drugs like Paxil is effective for patients in that age group. The FDA has chosen to rely on increased warnings.
Check out the following articles for more information about Paxil, filing a Paxil lawsuit and finding a Paxil attorney:
- For more information about Paxil, see Drug Overview: Paxil Side Effects and Claims
- For more information about Paxil side effects, see Paxil Side Effects – Suicide, Birth Defects & Death from Coronary Artery Disease
- For more information about Paxil updates, see Paxil Information and Warnings
- If you would like to learn more about Paxil lawsuits, see Paxil Lawsuits, Litigation & Lawyers
- To learn more about Paxil attorneys and how to find one, see Hiring a Paxil Attorney and Lawyer